In November 2020 the Advisory Council on the Misuse of Drugs advised that GHB should become a Class B drug rather than Class C – see Assessment of the harms of gamma-hydroxybutyric acid, gamma-butyrolactone, and closely related compounds – November 2020. Advisory Council on the Misuse of Drugs

In March 2021 Home Secretary Priti Patel said GHB would now move from a Class C to a Class B drug. The Home Office said associated substances GBL and 1,4-BD – which convert to GHB in the body – would also be moved into Class B. It added that, in future, the law would require a licence for anyone wishing to possess the associated substances for “legitimate” purposes.

13 czerwca 202121Ch0sen37 pisze:

Miałem rozbić butlę i wylizać resztki, ale wymyśliłem bardziej cywilizowany sposób - przepłukałem sokiem. Przynajmniej nie mam już nic pod ręką